Finance

Lists
Why is 3759 down 2,22%?
Dive Deeper
3759:HKG
Pharmaron Beijing Ord Shs H
HK$26,40
-2,22%
(-0,60) 1D
16 Okt., 16:08:14 GMT+8  ·   HKD
All symbols
SymbolPriceChange% Change
Generating top insights for 3759...
Open
HK$27,50
High
HK$28,28
Low
HK$24,64
Mkt. cap
74,56 mjd
Avg. vol.
5,53 m
Volume
10,40 m
Dividend
0,87%
Quarterly dividend
HK$0,06
Ex-dividend date
07 Jul. 2026
P/E ratio
23,70
52-wk high
HK$34,86
52-wk low
HK$14,45
EPS
HK$1,11
No. of employees
27 k
Open
HK$27,50
High
HK$28,28
Low
HK$24,64
Mkt. cap
74,56 mjd
Avg. vol.
5,53 m
Volume
10,40 m
Dividend
0,87%
Quarterly dividend
HK$0,06
Ex-dividend date
07 Jul. 2026
P/E ratio
23,70
52-wk high
HK$34,86
52-wk low
HK$14,45
EPS
HK$1,11
No. of employees
27 k
News stories
From web sources and news partners
About Pharmaron Beijing Ord Shs H
CEOBoliang Lou
Employees27,3 k
Founded01 Jul. 2004
Headquarters-
SectorHealth care
Websitepharmaron.cn
Last report
20 Aug. 2026
Fiscal period
Q2 2026
- / CNÂ¥0,28
Revenue / Est. (CNY)
4,02 mjd / 3,98 mjd
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
3,64 mjd
4,01 mjd
3,58 mjd
4,02 mjd
Cost of goods sold
2,38 mjd
2,57 mjd
2,42 mjd
2,70 mjd
Cost of revenue
2,38 mjd
2,57 mjd
2,42 mjd
2,70 mjd
Research and development expenses
141,14 m
184,42 m
139,77 m
156,06 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
540,84 m
553,55 m
520,12 m
587,74 m
Operating expense
744,80 m
809,09 m
701,15 m
782,02 m
Total operating expenses
3,13 mjd
3,38 mjd
3,12 mjd
3,48 mjd
Operating income
519,36 m
629,52 m
461,69 m
538,28 m
Other non operating income
-37,81 m
36,17 m
-48,69 m
46,54 m
EBT including unusual items
516,18 m
583,78 m
412,76 m
513,42 m
EBT excluding unusual items
478,50 m
626,67 m
396,21 m
436,35 m
Income tax expense
102,94 m
94,46 m
102,35 m
112,13 m
Effective tax rate
19,94%
16,18%
24,80%
21,84%
Other operating expenses
56,34 m
34,47 m
29,75 m
32,75 m
Net income
439,52 m
522,99 m
335,36 m
414,83 m
Net profit margin
12,06%
13,04%
9,37%
10,33%
Earnings per share
0,27
0,33
-
-
Interest and investment income
12,46 m
9,47 m
34,76 m
16,83 m
Interest expense
-47,49 m
-51,15 m
-51,56 m
-48,40 m
Net interest expenses
-35,03 m
-41,68 m
-16,80 m
-31,58 m
Depreciation and amortization charges
-
-
-
-
EBITDA
735,19 m
881,17 m
713,34 m
834,44 m
Gain or loss from assets sale
-3,36 m
4,69 m
-
-5,29 m
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google-programme